Low frequency of HLA-A*0201 allele in patients with epstein-barr virus- positive nasal lymphomas with polymorphic reticulosis morphology

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 195-199

  Kanno, Hiroyuki ^a,e   Kojya, Shizuo ^b   Li, Ting ^a,d   Ohsawa, Masahiko ^a   Nakatsuka, Shin ichi ^a   Miyaguchi, Mamoru ^a   Harabuchi, Yasuaki ^c   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; LYMPHOMA; MALE; PRIORITY JOURNAL; RETICULOSIS;

ADULT; AGED; ALLELES; DNA, VIRAL; EPITOPES; FEMALE; GENE FREQUENCY; HERPESVIRUS 4, HUMAN; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; JAPAN; LYMPHOMA; MALE; MIDDLE AGED; PARANASAL SINUS NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETICULOENDOTHELIOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034661754     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<195::AID-IJC6>3.0.CO;2-0     Document Type: Article

References (38)

1. AKAZA, T., IMANISHI, T., FUJIWARA, K., TOKUNAGA, K., JUJI, T., YASHIKI, S. and SONODA, S., HLA allele and haplotype frequencies in Japanese [in Japanese]. Transplantation Now. 7(Suppl.), 87-99 (1994).
2. AOZASA, K., OHSAWA, M. and KANNO, H., Pyothorax-associated lymphoma: A distinctive type of lymphoma strongly associated with Epstein-Barr virus. Adv. Anat. Pathol., 4, 58-63 (1997).
3. AOZASA, A., OHSAWA, M., TAJIMA, K., SASAKI, R., MAEDA, H., MATSUNAGA, T. and FRIEDMANN, I., Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int. J. Cancer, 44, 63-66 (1989).
4. AOZASA, K., YANG, W.-I., LEE, Y.B., PAN, W., WU, Y.-F., HORIUCHI, K., HYUN, B.H. and TAJIMA, K., Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int. J. Cancer, 52, 673-674 (1992).
5. BROOKS, L., YAO, Q.Y., RICKINSON, A.B. AND YOUNG, L.S., Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells; Coexpression of EBNAI. LMP1, and LMP2 transcripts. J. Virol., 66, 2689-2697 (1992).
6. BROWNING, M.J., KRAUSA, P., ROWAN, A., BICKNELL, D.C., BODMER, J.G. and BODMER W.F., Tissue typing the HLA-A locus from genomic DNA by sequence-specilic PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. nat. Acad. Sci. (Wash.), 90, 2842-2845 (1993).
7. BURT, R.D., VAUGHAN, T.L., NISPEROS, B., SWANSON, M. and BERWICK, M.A., Protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int. J. Cancer, 56, 465-467 (1994).
8. CHIANG, A.K.S., TAO, Q., SRIVASTAVA, G. and HO, F.S.C., Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int. J. Cancer, 68, 285-290 (1996).
9. DEACON, E. M., PALLESEN, G., NIEDOBITEK, G., CROCKER, J., BROOKS, L., RICKINSON, A.B. and YOUNG, L.S., Epstein-Barr virus and Hodgkin's disease; Transcriptional analysis of virus latency in the malignant cells. J. exp. Med., 177, 339-349 (1993).
10. EICHEL, B.S., HARRISON Jr., E.G., DEVINE, K.D., Scanlon, P.W. and BROWN, H.A., Primary lymphoma of the nose including a relationship to lethal midline granuloma. Amer. J. Surg., 112, 597-605 (1966).
11. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood, 87, 1466-1473 (1996).
12. EPSTEIN, M.A., ACHONG, B.G. and BARR, Y.M., Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, 1, 702-703 (1964).
13. FLEISCHHAUER, K., ZINO, E., MAZZI, B., SEVERINI, G.M., BENAZZI, E. and BORDIGNON, C., HLA-A*02 subtype distribution in Caucasians from northern Italy: identification of A*0220. Tissue Antigens, 48, 673-679 (1996).
14. FUKAYAMA, M., IBUKA, T., HAYASHI, Y., OOBA, T., KOIKE, M. and MIZUTANI, S., Epstein-Barr virus in pyothorax-associated pleural lymphoma. Amer. J. Pathol., 143, 1044-1049 (1993).
15. GAO, X., JAKOBSEN, I.B. and SERJEANTSON, S.W., Characterization of the HLA-A polymorphism by locus-specific polymerase chain reaction amplipication and oligonucleotide hybridization. Hum. Immunol., 41, 267-279 (1994).
16. KANNO, H., OHSAWA, M., HASHIMOTO, M., IUCHI, K., NAKAJIMA, Y. and AOZASA, K., HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas. Int. J. Cancer, 82, 630-634 (1999).
17. KANNO, H., WOLFINBARGER, J.B. and BLOOM, M.E., Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J. Virol., 67, 2075-2082 (1993).
18. KHANNA, R., BURROWS, S.R., KURILLA, M.G., JACOB, C.A., MISKO, I.S., SCULLEY, T.B., KIEFF, E. and MOSS, D.J., Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J. exp. Med., 176, 169-176 (1992).
19. KHANNA, R., BURROWS, S.R., NICHOLLS, J. and POULSEN, L.M., Identification of cytotoxic T cell epitopes wilhin Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 subtype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Europ. J. Immunol., 28, 451-458 (1998).
20. KIMURA, A., DATE, Y. and SASAZUKI, T., DNA typing of HLA-A gene [in Japanese]. Transplantation Now. 7(Suppl.), 10-22 (1994).
21. KRAUSA, P., BODMER, J.G. and BROWNING, M.J., Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens, 42, 91-99 (1993).
22. KRAUSA, P., BRYWKA III, M., SAVAGE, D., HUI, K.M., BUNCE, M., NGAI, J.L.F., TEO, D.L.T., ONG, Y.W., BAROUCH, D., ALLSOP, C.E.M., HILL, A.V.S., MCMICHAEL, A.J., BODMER, J.G. and BROWNING, M.J., Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens, 45, 223-231 (1995).
23. LEE, S.P., THOMAS, W.A., MURRAY, R.J., KHANIM, F., KAUR, S., YOUNG, L.S., ROWE, M., KURILLA, M. and RICKINSON, A.B., HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol., 67, 7428-7435 (1993).
24. LEE, S.P., TIERNEY, R.J., THOMA, W.A., BROOKS, J.M. and RICKINSON, A.B., Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol., 158, 3325-3334 (1997).
25. MINAROVITS, J., HU, L.-F., IMAI, S., HARABUCHI, Y., KATAURA, A., MINAROVITS-KORMUTA, S., OSATO, T. and KLEIN, G., Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J. gen. Virol., 75, 77-84 (1994).
26. MURRAY, R.J., WANG, D., YOUNG, L.S., WANG, F., ROWE, M., KIEFF, E. and RICKINSON, A.B., Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol., 62, 3747-3755 (1988).
27. OHSAWA, M., NAKATSUKA, S., KANNO, H., MIWA, H., KOJYA, S., HARABUCHI, Y., YANG, W.-I. and AOZASA, K., Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. Int. J. Cancer, 81, 865-870 (1999).
28. OHSAWA, M., TOMITA, Y., HASHIMOTO, M., YASUNAGA, Y., KANNO, H. and AOZASA, K., Malignant lymphoma of the adrenal gland: Its possible correlation with the Epstein-Barr virus. Mod. Pathol. 9, 534-543 (1996).
29. OUDEJANS, J.J., JIWA, N.M., KUMMER, J.A., HORSIMAN, A., VOS, W., BAAK, J.P.A., KLUIN, P.H.M., VAN DER VALK, P., WALBOOMERS, J.M.M. and MEIJER, C.J.L.M., Analysis of major histocompatibility complex class I expression on Reed-Sternherg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. Blood, 87, 3844-3851 (1996).
30. POPPEMA, S. and VISSER, L., Epstein-Barr virus positivity in Hodgkin's disease does not correlate with an HLA A2-negative phenotype. Cancer, 73, 3059-3063 (1994).
31. REN, E.C., LAW, G.C.T. and CHAN, S.H., HLA-A2 allelic microvariants in nasopharyngeal carcinoma. Int. J. Cancer. 63, 213-215 (1995).
32. RICKINSON, A.B. and MOSS, D.J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Ann. Rev. Immunol., 15, 405-431 (1997).
33. SU, I.-J., HSIEH, H.-C., LIN, K.-H., UEN, W.-C., KAO, C.-L., CHEN, C.-J., CHENG, A.-L., KADIN, M.E. and CHEN, J.-Y., Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood, 77, 799-808 (1991).
34. THOMAS, J.A., HOTCHIN, N.A., ALLDAY, M.J., AMLOT, P., ROSE, M., YACOUB, M. and Crawford, D.H., Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation, 49, 944-953 (1990).
35. TOMITA, Y., OHSAWA, M., MISHIRO, Y., KUBO, T., MAESHIRO, N., KOJYA, S., NODA, Y. and AOZASA, K., The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts in Japan. Lab. Invest., 73, 190-196 (1995).
36. TOMITA, Y., OHSAWA, M., QIU, K., HASHIMOTO, M., YANG, W.-I., KIM, G.-E. and AOZASA, K., Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: Close association with CD56+ immunophenotype and polyniorphic-reticulosis morphology. Int. J. Cancer, 70, 9-13 (1997).
37. WEISS, L.M., MOVAHED, L.A., WARNKE, R.A. and SKLAR, J., Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med., 320, 502-506 (1989).
38. ZUR HAUSEN, H., SCHULTE-HOLTHAUSEN, H., KLEIN, G., HENLE, W., HENLE, G., CLIFFORD, P. and SANTESSON, L., EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (Lond.), 228, 1056-1058 (1970).